Literature DB >> 3645999

Human T-cell lymphotropic virus-III (HTLV-III) seropositivity and related disease among 71 consecutive patients in whom tuberculosis was diagnosed. A prospective study.

A E Pitchenik, J Burr, M Suarez, D Fertel, G Gonzalez, C Moas.   

Abstract

The incidence of tuberculosis has recently risen in Southeast Florida. In order to determine the number and proportion of tuberculosis cases and the characteristics of tuberculosis that might be related to human T-cell lymphotrophic virus-III (HTLV-III) infection, all patients seen by the Dade County Florida Public Health Department-Tuberculosis Clinic during a 6-month period were medically evaluated and screened for HTLV-III antibody by an enzyme-linked immunosorbent assay. Of 71 consecutive patients confirmed to have tuberculosis (70 by culture) during the study period, 22 (31%) were seropositive and 49 (69%) were seronegative for HTLV-III antibody. The seropositive group had a significantly higher proportion of patients who were black, Haitian, and within the age group of 25 to 44 yr. The seropositive group also had a significantly higher rate of mild-to-moderate serum aspartate transaminase elevations (less than or equal to 5 times normal), tuberculin skin test false negativity, extrapulmonary tuberculosis (especially lymphatic), and pulmonary tuberculosis with an atypical radiographic picture. The seropositive group had a significantly lower proportion of patients with sputum cultures positive for M. tuberculosis. There was no significant difference between the groups with respect to the proportion of patients with positive sputum smears when sputum cultures were positive, serious antituberculosis drug reactions (requiring discontinuation of therapy), or percent of home contacts who were tuberculin skin tested and found to be positive. At the time of the diagnosis of tuberculosis, only 6 (27%) of the seropositive patients with tuberculosis had clinical evidence of AIDS or AIDS-related complex (unexplained thrush).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3645999     DOI: 10.1164/arrd.1987.135.4.875

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  24 in total

Review 1.  Antigens of the Mycobacterium avium, Mycobacterium intracellulare complex.

Authors:  S L Morris
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

2.  Spectrum of tuberculosis in patients with HIV infection in British Columbia: report of 40 cases.

Authors:  M Korzeniewska-Kosela; J M FitzGerald; S Vedal; E A Allen; M T Schechter; L Lawson; P Phillips; W Black; J S Montaner
Journal:  CMAJ       Date:  1992-06-01       Impact factor: 8.262

3.  Estimating HIV levels and trends among patients of tuberculosis clinics.

Authors:  E McCray; I M Onorato; B I Miller; T J Dondero; A B Bloch
Journal:  Public Health Rep       Date:  1990 Mar-Apr       Impact factor: 2.792

Review 4.  AIDS-related mycobacterial disease.

Authors:  F M Collins
Journal:  Springer Semin Immunopathol       Date:  1988

5.  Tuberculosis and HIV infection--new opportunities for an old pathogen.

Authors:  R E Chaisson
Journal:  West J Med       Date:  1989-06

6.  Universal HIV screening at a major metropolitan TB clinic: HIV prevalence and high-risk behaviors among TB patients.

Authors:  S E Weis; B Foresman; P E Cook; K J Matty
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

Review 7.  Tuberculosis in patients with human immunodeficiency virus infection. Review of current concepts.

Authors:  C P Theuer
Journal:  West J Med       Date:  1989-06

8.  Tuberculous pericarditis as the first manifestation of AIDS.

Authors:  J Pedro-Botet; T Auguet; J Coll; S Pons; J Rubiés-Prat
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

Review 9.  Tuberculosis and HIV disease: two decades of a dual epidemic.

Authors:  Muktar H Aliyu; Hamisu M Salihu
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

Review 10.  New developments in tuberculosis and HIV infection: an opportunity for prevention.

Authors:  J R Curtis; T M Hooton; C M Nolan
Journal:  J Gen Intern Med       Date:  1994-05       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.